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Although therapeutic community (TC) treatment is a promising intervention for substance use 
disorders, a primary obstacle to successful treatment is premature attrition. Because of their 
prevalence within substance use treatment facilities, personality disorder (PD) diagnoses have 
been examined as predictors of treatment completion. Prior research on TC outcomes has 
focused almost exclusively on antisocial personality disorder (ASPD), and the results have been 
mixed. The current study extends previous research by examining the impact of the 10 Axis II 
PDs on early (first 30 day) attrition as well as overall time to dropout in a 9-month residential 
TC. Survival analyses indicated that borderline was the only PD negatively related to overall 
program retention. In contrast, ASPD, as well as histrionic PD, were related to very early 
attrition but not to overall program retention. Early assessment and identification of at-risk 
individuals may improve treatment retention and outcome for TC treatment. 
 







     Therapeutic community (TC) treatment is a potentially effective psychosocial intervention for 
reducing substance use, criminality, unemployment, and other psychosocial problems 
experienced by addicted individuals1. Several large-scale studies2-4 have found significant and 
sustained improvements following successful completion of a TC typically after 6-12 months of 
residential treatment5. These multi-site studies indicate that the most stable predictor of positive 
treatment outcomes is retention in the treatment3-9. Unfortunately, it is common in intensive 
residential TCs for as many as 50% of residents to drop out within the first month and another 
25-40% or more to drop out during subsequent months, often leaving as few as 10% of 
admissions who receive a moderately to maximally effective dose of this treatment modality10.  
Identification of factors associated with very early attrition and poor longer term retention is 
important to help recognize individuals who may be at high risk for poor outcomes and for 
whom additional intervention might be necessary.  
     We evaluated the impact of the 10 Axis II personality disorders (PDs) on very early attrition 
(within first 30 days) as well as overall time to dropout during a 9-month treatment program. 
PDs are the most common form of co-occurring psychiatric disorder found in TCs11-15 and the 
severe and persistent cognitive, emotional, interpersonal, and behavioral problems characterizing 
these disorders contribute to poor outcomes in substance abuse treatment as well as a variety of 
psychiatric disorders16. Median prevalence rates of Axis II disorders are especially high (70-
80%) among drug dependent persons treated in inpatient or residential settings17. A systematic 
review of the literature18 found that PDs, particularly antisocial (ASPD) and borderline (BPD), 
were consistently associated with risks for early drop out from all types of substance abuse 
treatment. Other studies19-23 have also documented poor outcomes for PDs in general, including 
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their negative association with treatment completion in a large sample of homeless military 
veterans in a residential rehabilitation facility24 and among a sample of 307 Norwegian drug 
abusers25.  
     TCs were specifically designed to address the attitude, behavioral, criminogenic, and 
personality problems that characterize severe addiction and ASPD. As such, ASPD might be 
expected to have no appreciable impact on retention in an effectively run TC. However, studies 
evaluating retention among ASPD in TCs have been mixed. Goldstein et al.26 compared patients 
who met full criteria for ASPD (i.e., adult criteria and evidence of conduct disorder in childhood) 
versus those who only displayed adult antisocial behavior. They found that the ASPD diagnosed 
group had poorer retention for the longer (i.e., 180 day) treatment program, but that the groups 
did not differ for the 90 day program. In contrast, Haller et al.27 (1997) reported that ASPD was 
positively related to treatment retention in a sample of pregnant women. Messina and colleagues 
found that ASPD, diagnosed with either self-report inventory28 or semi-structured interview29 
was unrelated to several outcome measures, including the completion of the 12 month TC. Most 
recently, Daughters et al.30 reported that, while ASPD status did not predict retention on its own, 
the interaction of ASPD and court-mandated status did predict early attrition in a sample of 236 
male TC patients. Considering these mixed findings for ASPD, continued study of its impact on 
TC retention would be helpful in supplementing and potentially clarifying the existing literature. 
     Although a TC’s highly structured, hierarchical social milieu, emphasizing positive and 
negative consequences, may be well suited to ASPD, such an intensive and confrontive peer 
pressure environment may not be an effective approach for PDs characterized by significant 
cognitive (e.g., paranoid), emotional (e.g., borderline), or interpersonal (e.g., avoidant) 
vulnerability or rigidity. We are aware of only a few other studies that have evaluated PDs other 
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than ASPD in relation to TC retention. Karterud et al.31 evaluated 97 patients in a Norwegian day 
hospital TC and divided the patients into four diagnostic groups: borderline, schizotypal, “other” 
PD, and no PD. Borderline and schizotypal groups had greater rates of attrition than did the other 
PD or no PD groups. Fals-Stewart32 also examined the MCMI-II 33 PD scales and found that 
schizoid and schizotypal scales were negatively related to length of stay within a TC, while 
histrionic and narcissistic scales were positively related.  
     The current study attempted to address several gaps in the literature by conducting a more 
thorough evaluation of the relation between all 10 PDs and two measures of retention (i.e., early 
attrition, defined as premature dropout within the first 30 days, and overall time to dropout from 
the 9-month treatment program). We chose these two frames because of their clinical relevance 
and because they corresponded to time frames chosen in prior research.  We also addressed the 
limitations of previous research31 which relied on unstructured clinical diagnoses, did not test all 
PDs, used a general index of retention (percent dropped out), and a lower intensity non-
residential TC milieu. Although previous studies have been mixed, we predicted that ASPD 
would not be related to either very early attrition or overall time to dropout. However, we 
predicted that borderline PD and several Cluster A (paranoid, schizoid, schizotypal) and Cluster 
C (avoidant, obsessive-compulsive) PDs characterized by severe cognitive, emotional, and 
interpersonal vulnerabilities would be related to reduced retention.  
Method 
Participants 
     We recruited adult and adolescent patients from a long-term residential TC treatment program 
for substance abuse located in an urban area in the Northeastern United States. For inclusion, 
patients had to be either adolescents (15-18 years; n = 49) or adults (19-65 years; n = 77) and 
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have a lifetime DSM-IV substance abuse or dependence diagnosisA. Seven additional patients 
provided informed consent, but were excluded based on inability to read or understand the 
consent or assessment forms based on the Slosson Oral Reading Test34. Patients with current 
suicidal or homicidal plans, severe medical illness, schizophrenia, or bipolar disorder were not 
eligible for admission to the residential program. Interested individuals provided consent and 
received the baseline packet of self-report materials from a research assistant. Participants 
received a $50 store gift card for completing the baseline assessment, $10 for month 1-5 
assessments, $60 for the month 6 and $70 for month 9 assessments. This study was approved by 
the Institutional Review Board at the authors’ institution. 
Materials 
     Personality disorders were assessed using the Schedule for Nonadaptive and Adaptive 
Personality (SNAP) 35. The SNAP is a self-report inventory that includes 375 items rated as true 
or false. It provides an assessment of three broad temperaments (i.e., positive affect, negative 
affect, and disinhibition) as well as 12 maladaptive trait scales that assess aspects of personality 
pathology (e.g., mistrust, aggression, and impulsivity). The SNAP also provides an assessment of 
the DSM-III-R36 personality disorders, using some items that overlap with those included in the 
trait scales. These PD scales can be scored dimensionally (i.e., summing the items) or can 
produce categorical variables for each diagnostic criterion that can then be counted to determine 
whether the individual reaches the diagnostic threshold. Scores on the SNAP PD scales obtained 
stability coefficients over a nine-month interval ranging from .59 (schizotypal) to .84 
(antisocial), with a median of .75 in a non-clinical sample37. SNAP PD scale scores have 
demonstrated validity when compared to semi-structured interview measures with a median 
convergent correlation of .5535. In addition, SNAP PD scores correlate strongly with scores from 
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other self-report PD instruments with a median convergent value of .62 across the 10 PDs38. In 
addition, portions of the Structured Clinical Interview for DSM-IV (SCID) were administered for 
descriptive purposes. 
Procedures 
     TC residents were approached about their interest in participating in research within one week 
of program admission. Eligible and interested residents provided informed consent and 
completed a baseline assessment which included the SNAP and then monthly and follow-up 
assessments during their participation in a randomized clinical trial of two active 
psychotherapies. All participants were admitted to the TC with a minimal length of stay of 9 
months and typically by referral through the criminal justice or child protection systems. APT 
Residential Services Division embraces most of the core elements that have defined a TC39. The 
program involves a highly organized, staff-guided, self-help positive peer pressure process 
focused especially on changing attitudes, perceptions and behaviors associated with drug use and 
criminality. Peers influence peers to promote learning and assimilation of social norms and 
skills. There are strict, explicit, behavioral norms with contingencies to promote self-control and 
responsibility. The first 30 days of treatment are spent in a semi-segregated “orientation group 
program” in which the rules and responsibilities are learned and residents are supported through 
their accommodation to this new milieu. The next 6 or more months are spent in the main TC 
program and then followed by 6 or more months in a higher status resident coordinator role or 
employment in the community during a re-entry phase. 
     Although community meetings and psychoeducational groups are important tools, peer 
encounter and other therapy groups are considered the core techniques aimed at change. These 
groups are meant to heighten each individual’s awareness of specific attitudes or behavioral 
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patterns that negatively affect the community and need to be changed for the individual to 
recover. All of these groups focus on changing cognitive, behavioral, and emotional processes 
that severely impede affiliation with the community and thus prevent socialization and 
maturation. In addition, there are an array of professional support services in place (group 
counseling, case management, medical care, psychiatric services, educational and vocational 
programming). Job or school functions are arranged in a hierarchy according to seniority and 
individual productivity such that progress leads to higher levels of management/coordination as 
well as additional privileges. This social organization reflects fundamental elements of the 
rehabilitative approach: self-help, trust in the community, responsible performance, honesty, 
hard work, tough love, and earned successes. These are conceptualized as necessary for long-
term recovery from addiction. 
Data Analyses 
     Although the primary result of interest was the impact of PDs on 9-month TC program 
retention, attrition in the very early phase of treatment is a significant clinical problem for all 
addiction treatment modalities. Therefore, we also chose to evaluate 30 day attrition because the 
first month (orientation phase) is a critical phase of adjustment to a TC where separate 
programming is provided and because this is the shortest duration used as an outcome variable in 
previous TC research. We first conducted univariate analyses using chi-square to evaluate early 
drop-out and Kaplan-Meier survival analyses to evaluate days retained in treatment. For these 
univariate analyses, each diagnostic group was compared to the group without a PD diagnosis. In 
order to evaluate which predictors showed the strongest relationship we then conducted 
multivariate analyses by entering all diagnoses simultaneously. Binary logistic regression was 
used for early dropout and Cox regression survival analyses for treatment retention. Finally, 
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because the field of PD research appears to be moving toward dimensional approaches for DSM-
540, we repeated the multivariate analyses using dimensional PD scores. For these analyses, the 
raw item scores for each SNAP scale were summed to create variables referred to as PD severity 
scores.  Again, early dropout was evaluated using binary logistic regression and Cox regression 
was used for overall retention.  
Results 
     One-hundred and twenty-six participants completed the baseline assessment and 17 (14%) 
dropped out before 30 days, and 81 of these participants (64%) did not complete the 9-month 
program B. Table 1 provides descriptive statistics on demographic variables as well as selected 
Axis I and Axis II PD diagnoses for the entire sample.  
Univariate Analyses 
     We first examined the impact of any PD diagnosis, by comparing those meeting criteria for 
one or more PDs (n = 75) to those without any PD diagnosis (n = 51) on both early attrition and 
overall time to dropout.  Five times as many patients with a PD diagnosis dropped out within the 
first 30 days compared to those without a PD diagnosis (see Table 2). Over the entire treatment, 
patients with any PD diagnosis completed significantly fewer days in treatment than those 
without a PD diagnosis. Chi-square results indicated that antisocial, histrionic, and paranoid PD 
diagnoses were significantly related to early attrition. However, when considering overall 
number of days in treatment, Kaplan-Meier analyses suggested that borderline, paranoid, and 





   Seeking to better understand the unique contribution of each individual PD, we then entered 
the ten PDs simultaneously into a binary logistic regression predicting the dichotomous variable 
of attrition within the first 30 days. Schizotypal diagnosis was excluded from the early attrition 
analyses because all 17 individuals meeting criteria for schizotypal remained in treatment at 30 
days, providing no variability in the outcome. As with the univariate analyses, ASPD and 
histrionic were significantly predictive of early attrition. However, in contrast to the univariate 
findings, the impact of a paranoid diagnosis was non-significant when all the diagnoses were 
considered simultaneously (see Table 3). Multivariate analyses of days until dropout indicated 
that BPD was the only diagnosis that evidenced a significantly shorter stay over the 9-month 
treatment. Figure 1 presents the cumulative survival for those with and without a BPD diagnosis.  
Dimensional Scores 
    Finally, in order to determine whether dimensional representations of these constructs would 
show comparable findings, we repeated the multivariate analyses using continuous measures of 
the PD constructs. A binary logistic regression on the early attrition variable showed that 
histrionic severity was significantly predictive of early attrition (Wald χ2 = 5.0, OR = 1.58, 95% 
CI = 1.06 – 2.36), while antisocial severity trended but was not significant (Wald χ2 = 3.1, p = 
.08; OR = 1.20, 95% CI = .98 – 1.47). Consistent with the categorical results above, a Cox 
proportional hazards regression indicated that borderline severity significantly predicted shorter 
treatment lengths, Wald χ2 = 4.40, p < .05; H.R. = 1.21, 95% CI  = 1.00 – 1.45.   
Discussion 
     Although TCs are a promising treatment modality for severe addiction, criminality, 
unemployment, and other psychosocial problems, research has indicated that premature attrition 
is negatively associated with these long-term outcomes3. The existing literature has provided 
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mixed findings with respect to ASPD and little information about the impact of other PDs on 
retention. In contrast with some other research26 our findings replicate those of Messina and 
colleagues28-29 who also reported that ASPD was unrelated to TC retention. Globally, the results 
of the current study are consistent with previous findings in demonstrating that the presence of 
any PD is associated with worse retention in a TC24-25. However, the effect appears to be more 
specific both in terms of specific diagnoses and treatment intervals. The current study suggests 
that when considered in isolation, individuals with baseline diagnoses of BPD, avoidant, and 
paranoid PDs had significantly fewer days in treatment, compared to individuals without a PD 
diagnosis. However, when all ten diagnoses were considered simultaneously only BPD remained 
significant, suggesting that it is most related to shorter duration, over the course of a 9-month 
treatment. Additionally, individuals with ASPD, histrionic, and paranoid PD diagnoses were 
significantly more likely than those without any diagnosis to drop out within the first 30 days of 
treatment. Nonetheless, multivariate analyses (in which all diagnoses were entered at once) 
indicated that only the findings for ASPD and histrionic remained significant. It is perhaps 
interesting that, although BPD was the diagnosis with the shortest overall treatment duration, it 
was not significantly related to early attrition in the first 30 days. 
     These findings indicate that individuals with high emotional reactivity (which characterizes 
BPD) are not prone to retention problems during the orientation phase of TC treatment when 
they are receiving highly structured psychoeducational group and individual meetings focused on 
adaptation to the program milieu. During these first 30 days, residents are also relatively 
segregated from the broader program population and stressors of peer confrontation and 
behavioral consequences. Our results suggest that BPD residents experience retention problems 
the longer that they are exposed to the more intensive environment of the regular TC program 
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which can be characterized by affectively-charged and interpersonally confrontive interactions 
with peers and staff. This type of demanding TC milieu contrasts with existing empirically 
supported treatments for BPD such as dialectical behavior therapy41 which focuses explicitly on 
balancing change with empathic acceptance and validation of the individual. Research suggests 
that this type of treatment can increase retention and treatment outcomes for emotionally 
dysregulated and vulnerable patients42-43. Symptoms associated with BPD might not substantially 
interfere with the initial orientation to the TC model, but might interfere with the longer-term 
effective utilization of the TC’s core treatment processes.  
     In this sense, the findings for BPD were almost completely opposite those for ASPD and 
histrionic as those PDs were both related to early attrition, but not to overall time spent in the 
TC. In contrast to BPD, the traits associated with ASPD, such as assertiveness, competitiveness, 
and tough-skinned independence, might lead to difficulty accepting the rules and regulations of 
the well-controlled environment. However, once the initial orientation period is over, those same 
traits might equip the individual for success within (or at least tolerance for) the confrontive TC 
atmosphere. The present findings for ASPD at the two time points might also explain its 
inconsistent relationship with TC completion in previous studies. The definition of treatment 
completion has varied greatly, from as few as 30 days30 to as long as 12 months28. This wide 
range of intervals across studies as well as the fact that ASPD might present greater risks early in 
treatment suggests that, in addition to programmatic differences across TCs, the previous 
research might have been capturing temporal variation.  
     The finding that histrionic PD is also associated with attrition within the first 30 days of 
treatment is somewhat more difficult to understand. Only one other study has examined the 
relationship between histrionic PD and TC completion and it suggested that histrionic scores 
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were positively related to overall length of treatment32. Nonetheless, that study used a version of 
the MCMI33 that researchers have suggested may assess only qualitative, and perhaps even 
adaptive, aspects of histrionic PD44. Histrionic is defined primarily by the need to be the center 
of attention and represented by traits such as exhibitionism. It is possible that such individuals 
also may not respond well to the early phases of TC orientation when they are segregated from 
the population and less able to engage the wider attention of all residents and staff. Nonetheless, 
the fact that the current study is the first to report that histrionic PD might be related to early TC 
attrition should be interpreted cautiously until it can be further tested in additional studies.  
     While the most robust findings were for BPD (in terms of overall treatment duration) and for 
ASPD and histrionic (in terms of attrition within the first 30 days), there were also other PDs that 
evidenced an increased risk for attrition. Notably, individuals diagnosed with paranoid PD 
completed fewer total days in treatment and were more likely to drop out within the first 30 days 
than individuals without a PD diagnosis. In both cases, the findings for paranoid PD were not 
significant when considered simultaneously with the other PD diagnoses. This perhaps suggests 
that the effect of paranoid might be accounted for by its comorbidity with other disorders, rather 
than its unique variance. Similarly, individuals with an avoidant PD diagnosis spent significantly 
fewer days in treatment than individuals without any PD diagnoses, but this effect was also not 
significant when considered in multivariate analyses. At a minimum these findings suggest that 
future studies of premature dropout should also consider paranoid and avoidant PD. 
     Finally, it is important to note that the present findings were not specific to diagnostic status 
defined categorically (i.e., presence vs. absence of the diagnosis) as analyses of dimensional 
scorings also obtained comparable results. This is particularly important as it appears 
increasingly likely that DSM-5 will incorporate a dimensional understanding of personality 
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pathology. Within the currently available proposal40 it appears that ASPD and BPD will continue 
to be included (although histrionic might be excluded) but will be rated along a continuum rather 
than categorically. If this model is indeed adopted, the dimensional results presented in the 
current study might be most relevant to future researchers and clinicians. 
Clinical Implications 
     A primary implication of the current study is the importance of thorough personality 
assessment at the outset of treatment within a TC. Specifically, identification of those traits and 
behaviors characteristic of BPD and ASPD, as well as perhaps histrionic, paranoid, and avoidant 
PDs, is essential as they predicted different retention challenges. The current results suggest that 
ASPD should be identified quickly and that specific interventions be targeted toward these 
individuals to assist in their engagement and orientation to the TC atmosphere. The findings 
suggest that the risk for attrition for these individuals is greatest at the beginning of treatment and 
that the personality traits associated with ASPD might have a negligible (or even protective) 
effect once they integrate into the TC. Individuals with high standing on BPD, on the other hand, 
appear to be at no greater risk for very early attrition in programs that do not require immediate 
immersion into the treatment milieu. Nonetheless, the fact that BPD predicted attrition prior to 
program completion, suggests that a TC might not be the optimal choice of treatment for these 
individuals. Perhaps this initial early period (i.e., first 30 days) can be utilized by identifying the 
individuals least likely to benefit from the TC and make programmatic adjustments or external 
referral to promote better treatment retention and outcome.  
Limitations 
     The current study provides data on the impact of PDs on TC retention at two different time 
points, but is not without limitations. While self-reports of PDs are the most common method of 
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assessment within the research literature, semi-structured interviews are considered to be the 
most valid method45. In addition, the version of the SNAP employed in the current study assesses 
the DSM-III-R categories. Although the differences between the PD scales on the SNAP34 and 
the SNAP-246 are relatively minor (typically only a few items were changed), the use of DSM-IV 
scales would be preferable. Finally, the initial sample size was larger than some previous 
examinations (e.g., 97 patients31 and 65 patients25) but was also smaller than others (e.g., 275 
patients28). Nonetheless, the low prevalence of some PDs within this sample perhaps reduced the 
ability to detect their impact on retention. This factor, combined with the gender imbalance 
typical of most TCs, prevented our evaluation of the effects of gender on retention for all PDs. 
Future studies that examine potential gender interactions would be particularly important for 
BPD and ASPD given the gender differences in these diagnoses47.  
Conclusions 
     This was the first study to evaluate the categorical and dimensional representation of all 10 
PDs in relation to two treatment retention milestones. Our results suggest that previously 
inconsistent findings for ASPD might be attributable to the length of the treatment interval used 
to define “completion.” Finally, the current study also indicated that BPD negatively relates to 
long-term retention suggesting that other treatment modalities or approaches for emotionally 





 Before combining results from the adolescent and adults, we carefully examined them for 
potential differences. Beyond age, t-tests and chi-square analyses did not indicate significant 
differences for racial or gender makeup. Significant differences were noted for lifetime substance 
diagnoses, with adults more likely to qualify for alcohol, opioid, and stimulant diagnoses while 
adolescents were more likely to be diagnosed with cannabis dependence. No differences were 
detected for lifetime rates of major depressive disorder or social phobia, but adults were more 
likely to have a diagnosis of post-traumatic stress disorder. Most importantly, chi-square 
analyses also did not detect significant differences in the diagnostic rate for any of the 10 PDs, 
which were the variables of interest in the current study. While diagnosis of PDs within DSM-IV 
(APA, 2000) is restricted to individuals over the age of 18, there is increasing evidence for the 
continuity of maladaptive personality functioning across this arbitrary threshold49-50. 
Additionally, the DSM-5 Personality and Personality Disorders Workgroup proposal40 does not 
include an age requirement. 
B
 Although 270 days represented completion of the formal treatment, some patients remained in 
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Table 1    
Descriptive Statistics for Overall Sample on 
Demographic Variables, SCID Axis I Diagnoses, 
and SNAP Personality Disorder Diagnoses 
   
Variable   
Overall        
(n = 126) 
  
Gender (%male)  78.6  
Race    
     Caucasian (%)  55.6  
     African-American (%)  27.6  
     Hispanic (%)  12.7  
     other (%)  4.8  
Age (M [SD])  26.9 (10.3)  
     Adult (%)  61.1  
Lifetime Substance Diagnosis    
     Alcohol (%)  69.7  
     Stimulant (%)  33.6  
     Opioid (%)  19.7  
     Cannabis (%)  37.7  
     other (%)  5.7  
Lifetime Axis I Diagnosis    
     Major Depression (%)  38.5  
     Social Phobia (%)  22.3  
     PTSD (%)  20.5  
Personality Disorder    
     Paranoid (%)  20.6  
     Schizoid (%)  7.1  
     Schizotypal (%)  13.5  
     Antisocial (%)  31.0  
     Borderline (%)  25.4 
 
     Histrionic (%)  24.6 
 
     Narcissistic (%)  10.3 
 
     Avoidant (%)  23.0 
 
     Dependent (%)  13.5 
 
     Obsessive-Compulsive (%) 3.2 
  
Notes: SCID = Structured Clinical Interview for 
DSM-IV- Axis I 48; PTSD = Post-Traumatic Stress 




Table 2          
Univariate Analyses for SNAP PD Diagnoses on Early Attrition and Overall Time to Dropout 
 Early Attrition (< 30 days)  Overall Time to Dropout (270 days) 
Diagnostic Group % Attrited  χ2 p 
 
Mean 95% CI  log-rank χ2 p 
Paranoid (26) 19% 4.88 .04  127.1 88.2 - 165.9  4.27 .04 
Schizoid (9) 22% 4.12 .10  141.8  67.9 - 215.7  1.17 .28 
Schizotypal (17) 0% .69 1.00  149.3 104.5 - 194.1  1.25 .26 
Antisocial (39) 26% 9.02 .00  133.5 100.0 - 167.1  3.25 .07 
Borderline (32) 13% 2.16 .20  114.0 83.4 - 144.7   11.06 .00 
Histrionic (31) 26% 8.62 .01  141.1 103.9 - 175.7  3.07 .08 
Narcissistic (13) 15% 2.32 .18  126.2 72.3 - 180.0  2.71 .10 
Avoidant (29) 14% 2.60 .18  134.4 98.0 - 170.9  4.57 .03 
Dependent (17) 18% 3.53 .10  136.9 88.2 - 185.6  1.94 .16 
OCPD (4) 25% 3.20 .21  202.8 102.2 - 303.3  .04 .85 
Any PD (75) 20% 6.72 .02  135.3 112.3 - 158.3  6.09 .01 
  
  
    
  
No PD (51) 4% - -  191.2 165.8 - 216.5  - - 
Notes: Early dropout present chi-square analyses using Fisher's exact test (two-sided). Treatment 
completion analyses present results from Kaplan-Meier survival analysis with data right-censored 
at 270 days. Each diagnostic group was compared to the group without any PD diagnoses, provided 
on the lowest row. SNAP = Schedule for Non-Adaptive and Adaptive Personality (Clark, 1993); 
PD = Personality Disorder; Mean = the mean number of days in treatment; CI = Confidence 
Interval. Numbers in parentheses indicate the number of patients who met criteria for the PD. 
OCPD = Obsessive-Compulsive Personality Disorder. PD = personality disorder. Values in 
boldface type indicate significance at p < .05.  
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Table 3         
Multivariate Analyses of SNAP PD diagnoses on early attrition and overall time to dropout 
 Early Dropout (< 30 days)  





χ2 OR 95% CI  Wald χ2 HR 95% CI  
Paranoid 2.23 3.49 .68 - 17.96  .38 1.26 .61 - 2.62  
Schizoid 1.97 5.26 .52 - 53.44  .10 1.16 .45 - 3.02  
Schizotypal .00    1.36 .58 .23 - 1.45  
Antisocial 5.53 5.16 1.31 - 20.22  .04 1.06 .60 - 1.88  
Borderline 1.44 .35 .06 - 1.93  4.47 1.89 1.05 - 3.40  
Histrionic 5.35 5.14 1.28 - 20.57  .08 1.09 .60 - 1.97  
Narcissistic .91 .28 .02 - 3.76  .23 .79 .29 - 2.11  
Avoidant .78 2.14 .39 - 11.67  1.31 1.45 .77 - 2.72  
Dependent .07 .80 .14 - 4.50  .03 .94 .42 - 2.07  
OCPD .52 3.57 .11 - 112.93  .62 .56 .13 - 2.39  
                  
Notes: Early attrition analyses present binary logistic regressions on presence of drop-out at 30 
days. Overall time to dropout analyses present Cox regression analyses for attrition over 9-
months. SNAP = Schedule for Nonadaptive and Adaptive Personality35. PD = Personality 
disorder. OR = Odds ratio; HR = Hazard ratio; 95% CI = 95% Confidence Interval. OCPD = 
obsessive-compulsive PD. Values in boldface type indicate significance at p < .05. * 







Figure 1.  
Cox Regression Survival Analysis for Borderline Personality Disorder Diagnosis 
 
Notes: n = 126; BPD = borderline personality disorder; Data right-censored at 270 days. 
